Dempze Nancy E Abbott Laboratories Transaction History
Dempze Nancy E
- $116 Million
- Q1 2024
A detailed history of Dempze Nancy E transactions in Abbott Laboratories stock. As of the latest transaction made, Dempze Nancy E holds 36,557 shares of ABT stock, worth $3.74 Million. This represents 3.58% of its overall portfolio holdings.
Number of Shares
36,557
Previous 35,725
2.33%
Holding current value
$3.74 Million
Previous $3.93 Million
5.67%
% of portfolio
3.58%
Previous 3.73%
Shares
27 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$16.9 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.6 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.59 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.65 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.18 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $179B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...